Showing Results : 1-1 of 1
Sort By :
  • LATEST MANUSCRIPTS IN Exploration of Targeted Anti-tumor Therapy
  • Gerhard Hamilton, Sandra Stickler, Barbara Rath. Integration of signaling pathway and bromodomain and extra-terminal domain inhibition for the treatment of mutant Kirsten rat sarcoma viral oncogene homolog cancer. Exploration of targeted anti-tumor therapy. 2023, 4 (5): 1027-1038
    Cited : 1
    Read More
  • Afrooz Mazidimoradi, Samane Sabet Birjandi, Hamid Salehiniya. Effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review. Exploration of targeted anti-tumor therapy. 2023, 4 (5): 1039-1058
    Cited : 1
    Read More
  • Marzieh Tahmasebi, Masoud Veissi, Seyed Ahmad Hosseini, Amir Jamshidnezhad. Effect of vitamin D supplementation on inflammatory markers and total antioxidant capacity in breast cancer women using a machine learning technique. Exploration of targeted anti-tumor therapy. 2023, 4 (5): 1059-1070
    Cited : 0
    Read More
  • Christos Ladias, Pavlos Papakotoulas, Maria Papaioannou, Nikolaos A Papanikolaou. Overcoming phenotypic switching: targeting protein-protein interactions in cancer. Exploration of targeted anti-tumor therapy. 2023, 4 (5): 1071-1081
    Cited : 1
    Read More
  • Abrahams Ocanto, Xabier Mielgo-Rubio, Javier Luna Tirado, Nuria Linares Mesa, Marta López Valcárcel, Sara Pedraza, Victoria Vera Barragan, Patricia Valencia Nieto, Juan Zafra Martín, Felipe Couñago. Coronavirus disease 2019 and lung cancer: where are we? Exploration of targeted anti-tumor therapy. 2023, 4 (5): 1082-1094
    Cited : 1
    Read More
  • Veronica Agostinelli, Zelmira Ballatore, Giulia Ricci, Alessandra Lucarelli, Michela Burattini, Lorenzo Mariotti, Claudia Catani, Valentina Tarantino, Rossana Berardi. Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology. Exploration of targeted anti-tumor therapy. 2023, 4 (5): 1095-1103
    Cited : 0
    Read More
  • Levi Arnold, Juan Pineda Gomez, Michael Barry, Marrion Yap, Laura Jackson, Thuc Ly, David Standing, Subhash B Padhye, Bernhard Biersack, Shrikant Anant, Sufi Mary Thomas. Acryl-3,5-bis(2,4-difluorobenzylidene)-4-piperidone targeting cellular JUN proto-oncogene, AP-1 transcription factor subunit inhibits head and neck squamous cell carcinoma progression. Exploration of targeted anti-tumor therapy. 2023, 4 (5): 1104-1121
    Cited : 0
    Read More
  • Youjun Li, Michael Karin, Edward V Prochownik. Cholesterol esterification and p53-mediated tumor suppression. Exploration of targeted anti-tumor therapy. 2023, 4 (5): 1122-1127
    Cited : 0
    Read More
  • Dimitrios Bouzianas, Stella Bouziana. A decade of CD4+ chimeric antigen receptor T-cell evolution in two chronic lymphocytic leukemia patients: were chronic lymphocytic leukemia cells present? Exploration of targeted anti-tumor therapy. 2023, 4 (5): 1128-1135
    Cited : 2
    Read More
  • Zelmira Ballatore, Amalia Goudas, Francesco Bozzi, Alessandra Lucarelli, Michela Burattini, Giulia Ricci, Francesco Savino, Rossana Berardi. A single experience in the conduction of clinical trial during COronaVIrusDisease-2019 pandemic. Exploration of targeted anti-tumor therapy. 2023, 4 (5): 793-800
    Cited : 0
    Read More
  • Pinelopi Samara, Michael Athanasopoulos, Anastasios Goulioumis, Ioannis Athanasopoulos. Malignant tumors of the external auditory canal: diagnosis, treatment, genetic landscape, biomarkers, and clinical outcome. Exploration of targeted anti-tumor therapy. 2023, 4 (5): 801-811
    Cited : 1
    Read More
  • Gowri Palanissami, Solomon F D Paul. AGEs and RAGE: metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers. Exploration of targeted anti-tumor therapy. 2023, 4 (5): 812-849
    Cited : 10
    Read More
  • Parth Malik, Ruma Rani, Raghu Solanki, Vishal Haribhai Patel, Tapan Kumar Mukherjee. Understanding the feasibility of chemotherapeutic and immunotherapeutic targets against non-small cell lung cancers: an update of resistant responses and recent combinatorial therapies. Exploration of targeted anti-tumor therapy. 2023, 4 (5): 850-895
    Cited : 5
    Read More
  • Abhishek Mahajan, Devendra Goyal, Ujjwal Agarwal, Vijay Patil, Shreya Shukla, Vanita Noronha, Amit Joshi, Nandini Menon, Kumar Prabhash. Exploring the implications of modified advanced lung cancer inflammation index on outcomes in patients with advanced non-small cell lung cancer. Exploration of targeted anti-tumor therapy. 2023, 4 (5): 896-911
    Cited : 0
    Read More
  • Sathammai Sathappa Supuramanian, Sid Dsa, Sitaram Harihar. Molecular interaction of metastasis suppressor genes and tumor microenvironment in breast cancer. Exploration of targeted anti-tumor therapy. 2023, 4 (5): 912-932
    Cited : 0
    Read More
 
 


Journal List
Links
Content Links
About Us

0